Cytokines are small proteins secreted by a variety of cells, which regulate not only cell growth and differentiation but also immune function by binding to their corresponding receptors. 1 Cytokines mainly include interleukin, colonystimulating factor (CSF), interferon, tumor necrosis factor, growth factor (GF) and chemokine. Chemokines are a class of cytokines with chemotactic activity and function by binding to G proteincoupled receptors. 2 Chemokines and their receptors have important roles in inflammation and tumors by regulating chemotaxis, immunoregulation and the behavior of various cells. 3 At present, about 50 chemokines and 20 chemokine receptors have been identified. 4 Classical chemokines are divided into four subfamilies, that is, the CC, CXC, CX3C and XC chemokines (Figure 1 ). The first two cysteines of the CC subfamily are juxtaposed. One or three amino-acid residues are inserted between the first two of four cysteine residues in the CXC and CX3C families, respectively. The XC family possesses one disulfide bond and the first and third cysteine residues are absent. 4 In addition to the classical chemokines, there is a class of atypical chemokines, known as the chemokine-like function (CLF) family, which possess chemotactic activity but do not have typical chemokine structural features. The members of the CLF family are diverse and include lipids (PAF and LTB4), peptides (C5a and fMLP), proteins (HMGB1) and secreted proteins (macrophage migration inhibitory factor, macrophage-CSF and vascular endothelial GF). Several new cytokines with chemotactic activity, including CKLF1, FAM19A4 and CYTL1 (Figure 1 ), have been identified in Peking University Center for Human Disease Genomics.
Human chemokine-like factor 1 (CKLF1) was first identified in U937 cell upon phytohemagglutinin stimulation. 5 CKLF1 exhibits chemotactic effects on a wide spectrum of leukocytes and nerve cells in vitro. 5, 6 CKLF1 has a CC motif in its C-terminal region and is a functional ligand for human C-C chemokine motif receptor 4 (CCR4), which is similar to TARC/C-C chemokine motif ligand 17 (CCL17) and MDC/CCL22. 7 CKLF1 can stimulate the proliferation of murine skeletal muscle cells and human bone marrow hematopoietic progenitor cells. 8 In addition, CKLF1 has a role in neuronal apoptosis after cerebral ischemia and reperfusion, and the production of inflammatory mediators and adhesion molecules are decreased in rats by treatment with an anti-CKLF1 antibody. 9 The two secreted forms of CKLF1 (C19 and C27) can stimulate antigen-presenting capability of immature dendritic cells via CCR4, and the C19 can inhibit chemotaxis induced by CKLF1. 10 In addition, CKLF1 regulates vascular smooth muscle cell migration and proliferation and facilitates neointima hyperplasia and atherosclerosis. 11 CKLF1 also participates in the development of rheumatic diseases, and the expression of CKLF1 in rheumatoid arthritis, osteoarthritis and ankylosing spondylitis is increased. 12 Additionally, CKLF1 is increased in response to psoriatic lesions and promotes the proliferation of microvascular endothelial cells, which correlates with extracellular signal-regulated kinase (ERK) 1/2-mitogen-activated protein kinase activation in psoriasis. 13 FAM19A4 (also called TAFA4) is a member of the TAFA family and is a classical secretory protein with CC and CXC motifs. It shows chemotactic activity on macrophages via formyl peptide receptor 1. 14 FAM19A4 can enhance macrophage phagocytosis of zymosan via increased phosphorylation of Akt and can increase the release of reactive oxygen species upon zymosan stimulation, which is similar to the function of fMLP. 14 The methylation level of FAM19A4 correlates with cervical intraepithelial neoplasia and cancer and may become a new diagnostic criterion for cervical cancer. 15 FAM19A4 also participates in the regulation of neuralgia and can regulate neuronal excitability through low-threshold receptors and may reduce the painful effects of chemical or inflammatory stimuli. 16 CYTL1, also known as C17 or C4ORF4, was first found in bone marrow and cord blood-derived CD34 + cells. CYTL1 is a classical secretory protein wiht 22-amino-acid signal peptide in the N-terminus. 17 CYTL1 and CCL2 have some similarity in the tertiary structure, and we identified that CCR2 was a functional receptor of CTYL1 using a series of experiments. CYTL1 can chemoattract monocytes/macrophages via the CCR2-ERK-dependent pathway. 18 CCL2/CCR2 has an important regulatory role in the inflammatory response and the process of occurrence and metastasis of tumors. 19 The Gene Expression Omnibus database shows that the expression of CYTL1 is significantly downregulated in some inflammatory diseases and CYTL1 plays an antiinflammatory role in a model of osteoarthritis. 20 CYTL1 is also downregulated in lung cancer, breast cancer and other tumors. Given the important role of CCR2 in tumors, whether CYTL1 affects tumor migration through CCR2 requires further study.
Cytokines with chemotactic activity participate in autoimmune diseases, tumors and other diseases, as well as in the regulation of the immune process. The CLF cytokines, together with classical chemokines, constitute a complex network within the regulation of the directional movement of immune cells. Further research will likely lead to more CLF cytokines being found and the development of drugs targeting CLF cytokines and related receptors will continue to be a hot topic in the future.
